Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Werewolf Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 46 | 44 | −2 |
| Shares | 19.1M | 21.0M | +1.88M (+9.9%) |
| Value | $78.0M | $94.5M | +$16.5M (+21.1%) |
New holders (4)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 25,996 | $117.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 19,558 | $88.0K | 0.01% |
| Denali Advisors LLC | 5,900 | $27.0K | 0.01% |
| China Universal Asset Management Co., Ltd. | 277 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 13,250 | $54.0K |
| Goldman Sachs Group Inc | 10,983 | $45.0K |
| Y-Intercept (Hong Kong) Ltd | 11,124 | $45.0K |
| New York State Common Retirement Fund | 187 | $1.00K |
| Barclays PLC | 108 | $0 |
| Credit Suisse AG | 14 | $0 |